Merck has had a successful track record of beating estimates, having surpassed EPS expectations 88% of the time and beating ...

Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...

The healthcare sector, including managed-care firms and drug powerhouses, is vastly underperforming the S&P 500 index. Here ...

Head and Neck Squamous Cell Carcinoma (HNSCC), also commonly known as Head and Neck cancers are a group of cancers that originate in the head and neck region of the human body. These include the oral ...